Liabooks Home|PRISM News
PRISM

#Merck

Total 1 articles

Interior of a Merck lab with a $70 billion revenue growth chart
EconomyEN
Merck Targets $70 Billion Revenue by mid-2030s to Counter Keytruda Patent Cliff

Merck (MSD) announced a revenue target of $70 billion by the mid-2030s, driven by new growth opportunities and a diversified pipeline to offset Keytruda's patent expiration.